Concepedia

AKT2 is essential to maintain podocyte viability and function during chronic kidney disease

Guillaume Canaud, Frank Bienaimé, Amandine Viau, Caroline Treins, William Baron, Clément Nguyen, Martine Burtin, Sophie Bérissi, Konstantinos Giannakakis, Andrea Onetti Muda,

Nature Medicine · 2013 · 216 citations · 49 references

DOIFull text

Open access

Concepts

References

49

Rictor, a Novel Binding Partner of mTOR, Defines a Rapamycin-Insensitive and Raptor-Independent Pathway that Regulates the Cytoskeleton

Dos D. Sarbassov, Siraj M. Ali, Do‐Hyung Kim et al. · Current Biology · 2004 · 2.7K citations · Full text

, , +12

Prolonged Rapamycin Treatment Inhibits mTORC2 Assembly and Akt/PKB

Dos D. Sarbassov, Siraj M. Ali, Shomit Sengupta et al. · Molecular Cell · 2006 · 2.6K citations · Full text

, , +6

Banff 07 Classification of Renal Allograft Pathology: Updates and Future Directions

Kim Solez, Robert B. Colvin, Lorraine C. Racusen et al. · American Journal of Transplantation · 2008 · 1.9K citations · Full text

, , +16

Insulin Resistance and a Diabetes Mellitus-Like Syndrome in Mice Lacking the Protein Kinase Akt2 (PKBβ)

Han Cho, James Mu, Jason K. Kim et al. · Science · 2001 · 1.8K citations

, , +17

The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A

Christian Faul, Mary Donnelly, Sandra Merscher et al. · Nature Medicine · 2008 · 985 citations · Full text

, , +17